Science is interesting and good. Potential is good. Progress is ok, but unfortunately the presentations did not meet my expectations and being in the medical sciences field i have realistic expectations. So, I opted out (disclosure changed accordingly) and will keep a close eye on this in the next 12 month. Having said that, if one is a loyal shareholder and are supporting the company for perhaps also personsl reasons that are beyond funancial insentive, then IMO it is a stock worth holding long term.
ATH Price at posting:
0.6¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)